JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RESI
3201
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $2.13M | ﹤0.01% |
178,722
+62,293
| +54% | +$675K |
2016 Q4
10 quarters
|
|
|
SINA
3202
DELISTED
Sina Corp
SINA
| $2.12M | ﹤0.01% |
48,903
-41,428
| -46% | -$2.17M |
2015 Q4
14 quarters
|
|
3203
Invesco Large Cap Growth ETF
PWB
$2.8B
| $2.12M | ﹤0.01% |
44,116
-1,828
| -4% | -$87K |
2016 Q1
13 quarters
|
|
3204
Mercury Systems
MRCY
$5.04B
| $2.12M | ﹤0.01% |
31,326
+19,878
| +174% | +$1.38M |
2016 Q2
12 quarters
|
|
3205
CALL
Itaú Unibanco
ITUB
$112B
| $2.12M | ﹤0.01% |
309,224
| – | – |
2017 Q4
6 quarters
|
|
3206
Viper Energy
VNOM
$8.09B
| $2.12M | ﹤0.01% |
71,768
-213,447
| -75% | -$6.61M |
2016 Q2
12 quarters
|
|
|
AXAS
3207
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.11M | ﹤0.01% |
96,785
-43,234
| -31% | -$1.05M |
2016 Q4
10 quarters
|
|
|
FLOW
3208
DELISTED
SPX FLOW, Inc.
FLOW
| $2.11M | ﹤0.01% |
52,289
+872
| +2% | +$32.3K |
2015 Q3
15 quarters
|
|
3209
Vanguard FTSE Pacific ETF
VPL
$8.75B
| $2.1M | ﹤0.01% |
31,814
+4,096
| +15% | +$268K |
2013 Q2
24 quarters
|
|
3210
Navios Maritime Partners
NMM
$2.64B
| $2.1M | ﹤0.01% |
160,144
+11,714
| +8% | +$156K |
2013 Q2
24 quarters
|
|
3211
Kontoor Brands
KTB
$3.6B
| $2.1M | ﹤0.01% |
+73,876
| New | +$2.2M |
2019 Q2
0 quarters
|
|
|
NGD
3212
DELISTED
New Gold Inc
NGD
| $2.1M | ﹤0.01% |
2,338,034
+1,087,652
| +87% | +$864K |
2013 Q2
24 quarters
|
|
3213
iShares MSCI Australia ETF
EWA
$1.22B
| $2.09M | ﹤0.01% |
92,393
-1,571,360
| -94% | -$34.4M |
2013 Q2
24 quarters
|
|
3214
CALL
Nektar Therapeutics
NKTR
$1.36B
| $2.08M | ﹤0.01% |
4,000
-2,000
| -33% | -$1M |
2018 Q2
4 quarters
|
|
|
SRDX
3215
DELISTED
Surmodics
SRDX
| $2.07M | ﹤0.01% |
51,898
+9,769
| +23% | +$412K |
2013 Q2
24 quarters
|
|
|
SPPI
3216
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.07M | ﹤0.01% |
237,536
+4,697
| +2% | +$42K |
2016 Q4
10 quarters
|
|
|
VPU
3217
Vanguard Utilities ETF
VPU
$7.96B
| $2.06M | ﹤0.01% |
15,605
-45,828
| -75% | -$5.99M |
2018 Q1
5 quarters
|
|
3218
TG Therapeutics
TGTX
$7.99B
| $2.06M | ﹤0.01% |
258,296
-11,702
| -4% | -$88.5K |
2016 Q4
10 quarters
|
|
3219
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
| $2.06M | ﹤0.01% |
26,833
-12,269
| -31% | -$912K |
2013 Q2
24 quarters
|
|
3220
Heritage Financial
HFWA
$1.13B
| $2.05M | ﹤0.01% |
70,554
+8,750
| +14% | +$263K |
2014 Q2
20 quarters
|
|
3221
AMN Healthcare
AMN
$1.42B
| $2.05M | ﹤0.01% |
38,190
-673
| -2% | -$34.1K |
2013 Q2
24 quarters
|
|
3222
CALL
Newell Brands
NWL
$2.36B
| $2.04M | ﹤0.01% |
+134,600
| New | +$2.01M |
2019 Q2
0 quarters
|
|
3223
Rapid7
RPD
$827M
| $2.04M | ﹤0.01% |
36,618
-31,954
| -47% | -$1.68M |
2015 Q3
15 quarters
|
|
3224
First Trust Cloud Computing ETF
SKYY
$3.47B
| $2.04M | ﹤0.01% |
35,426
+3,008
| +9% | +$177K |
2015 Q4
14 quarters
|
|
3225
CALL
PG&E
PCG
$37.5B
| $2.04M | ﹤0.01% |
85,000
-171,100
| -67% | -$3.44M |
2019 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.